Article
Melanoma genomics - will we go beyond BRAF in clinics?
Journal of cancer research and clinical oncology - 28 Sept 2024
Mirek Justyna, Bal Wiesław, Olbryt Magdalena
Abstract excerpt
In the era of next-generation sequencing, the genetic background of cancer, including melanoma, appears to be thoroughly established. However, evaluating the oncogene BRAF mutation in codon V600 is still the only companion diagnostic genomic test commonly implemented in clinics for molecularly targeted treatment of advanced melanoma. Are we wasting the collected genomic data? Will we implement our current genomic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
